Optimer Pharmaceuticals Inc (NASDAQ:OPTR)
| 14.44 Data as of Jun 18 |  +0.01 / +0.07%Today’s Change | 8.64 Today|||52-Week Range 16.80 | +59.56% Year-to-Date |
Latest OPTR News | Press Releases
No recent news for Optimer Pharmaceuticals Inc.
Today’s Trading
| Previous close | 14.43 |
| Today’s open | 14.41 |
| Day’s range | 14.15 - 14.59 |
| Volume | 392,566 |
| Average volume (3 months) | 910,463 |
| Market cap | $703.0M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | -558.82% |
| Earnings growth (this year) | -186.25% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -29.97% |
| P/E ratio | NM |
| Price/Sales | 4.22 |
| Price/Book | 5.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AVNRAvanir Pharmaceutica... | +0.10 | +2.10% |
| ACHNAchillion Pharmaceut... | +0.08 | +1.01% |
| LGNDLigand Pharmaceutica... | +1.11 | +3.53% |
| MACKMerrimack Pharmaceut... | +0.01 | +0.16% |
Data as of 4:00pm ET, 06/18/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $101.5M |
| Annual profit (last year) | -$37.0M |
| Net profit margin | -36.43% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Henry A. McKinnell, Jr., PhD |
Chief Operating Officer Eric Sirota, MBA |
Corporate headquarters Jersey City, New Jersey |
Forecasts
